Clinical Trial Update: Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a phase 1/2 study evaluating safety and efficacy of epcoritamab combinations in adults with diffuse large B-cell lymphoma and follicula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)

Snippet

Sponsor: Genmab | Conditions: Diffuse Large B-Cell Lymphoma, Follicular Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING